# ZILBRYSQ

NDC: 50474-992
Generic name: zilucoplan
Labeler / Manufacturer: UCB, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20240103

FDA application: NDA216834

## Active ingredients

- ZILUCOPLAN: 40 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50474-992"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50474-992
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f1d53d6-e495-4a3a-8bb9-680a15d25034